The countries participating in the Fair and Affordable Pricing initative held an information sharing workshop (with a product-specific focus) to facilitate voluntary cooperation on the critical assessment of medicinal products undergoing evaluation for reimbursement. During the workshop - initiated by Hungary - participants discussed the approach towards the identification, quantification, and interpretation of limitations of health economic evulations and shared their practices towards setting up a new base case for the appraisal process.